Diabetes Mellitus, Type 2

Showing NaN - NaN of 135

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Trial in United Kingdom (FreeStyle Libre 3 Continuous Glucose Monitoring System., Self monitoring of blood

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • FreeStyle Libre 3 Continuous Glucose Monitoring System.
  • Self monitoring of blood glucose
  • Birmingham, United Kingdom
  • +16 more
Jul 12, 2023

Diabetes, Type 2 Trial (Digital Health Coaching, Food Box Delivery, Remote Patient Monitoring (RPM))

Recruiting
  • Diabetes Mellitus, Type 2
  • Digital Health Coaching
  • +3 more
  • Birmingham, Alabama
    UAB Hospital-Highlands
Feb 2, 2023

Diabetes, Type 2, Peripheral Arterial Disease Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Recruiting
  • Diabetes Mellitus, Type 2
  • Peripheral Arterial Disease
  • Birmingham, Alabama
  • +179 more
Jan 23, 2023

Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Recruiting
  • Obesity
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +73 more
Jan 24, 2023

Diabetes, Type 2, Cardiovascular Diseases Trial in United States (Intense Education Intervention)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Intense Education Intervention
  • Birmingham, Alabama
  • +43 more
Jan 19, 2023

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +393 more
Jan 17, 2023

Diabetes, Type 2 Trial in Worldwide (Oral semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Oral semaglutide
  • Placebo (semaglutide)
  • Birmingham, Alabama
  • +73 more
Jan 13, 2023

Diabetes, Type 2, Preterm Birth, Pregnancy, High Risk Trial in Birmingham (Sliding Scale Insulin, Up-Titration of Home Insulin,

Recruiting
  • Diabetes Mellitus, Type 2
  • +3 more
  • Sliding Scale Insulin
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 7, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Diabetes, Type 2 Trial in United States (iRF System Hepatic Denervation)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • iRF System Hepatic Denervation
  • Birmingham, Alabama
  • +7 more
Aug 10, 2022

Type2 Diabetes, Diabetes, Diabetes, Type 2 Trial in Worldwide (Tirzepatide Dose 1, Tirzepatide Dose 2, Placebo)

Recruiting
  • Type2 Diabetes
  • +7 more
  • Tirzepatide Dose 1
  • +2 more
  • Birmingham, Alabama
  • +55 more
Aug 8, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, sitagliptin, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +241 more
Jul 11, 2022

Diabetes, Type 2 Trial in Worldwide (IcoSema, Semaglutide 1 mg)

Recruiting
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Jun 28, 2022

Diabetes, Type 2 Trial in Worldwide (Dapagliflozin, Saxagliptin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Sacramento, California
  • +122 more
Mar 21, 2022

Diabetes, Type 2 Trial in United States (Gan & Lee Insulin Glargine Injection, LantusĀ®)

Completed
  • Diabetes Mellitus, Type 2
  • Gan & Lee Insulin Glargine Injection
  • LantusĀ®
  • Birmingham, Alabama
  • +56 more
Mar 23, 2022

Diabetes, Type 2 Trial in United States (Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide 2.4 mg
  • +3 more
  • Birmingham, Alabama
  • +17 more
Mar 14, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +128 more
Feb 14, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Diabetes, Type 2 Trial in Birmingham (High-Fruit Diet)

Recruiting
  • Diabetes Mellitus, Type 2
  • High-Fruit Diet
  • Birmingham, Alabama
    Department of Nutrition Sciences, University of Alabamam at Birm
Nov 30, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +184 more
Jul 1, 2021

Peripheral Arterial Disease (PAD), Diabetes (DM), Diabetes, Type 1 Trial in Worldwide (REX-001, Placebo)

Recruiting
  • Peripheral Arterial Disease (PAD)
  • +5 more
  • Innsbruck, Austria
  • +27 more
May 4, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Oct 26, 2020

Diabetes, Type 2 Trial in Worldwide (MEDI0382 low dose, MEDI0382 mid dose, MEDI0382 high dose)

Completed
  • Diabetes Mellitus, Type 2
  • MEDI0382 low dose
  • +4 more
  • Birmingham, Alabama
  • +118 more
Jul 31, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020